Last reviewed · How we verify
NCT05756946
Guided Tissue Regeneration With a Periodontal Dressing
NA trial testing periodontal dressing (coe-pak) in Periodontal Diseases in 24 participants. Completed in 15 April 2023.
10 April 2023
Quick facts
| Lead sponsor | Arab American University (Palestine) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 24 |
| Start date | 1 March 2023 |
| Primary completion | 10 April 2023 |
| Estimated completion | 15 April 2023 |
| Sites | 1 location across Palestinian Territories |
Drugs / interventions tested
- periodontal dressing (coe-pak)
- Guided Tissue Regeneration
Conditions studied
- Periodontal Diseases — all drugs for Periodontal Diseases →
Sponsor
Arab American University (Palestine)
Who can join
Adults 18 to 75, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, controlled split-mouth study will include 24-40 patients. After GTR, a test and a control side will be selected by means of a computer-generated randomization list. Test sides will receive a periodontal dressing (Coepak") for 14 days and the control sides will receive no periodontal dressing. After 14 days the periodontal dressing will be removed and the pain experience will be recorded. After 6-9 months, the clinical periodontal parameters will be recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05756946
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Periodontal Diseases
Currently open trials in the same condition.
- NCT07358104 — Efficacy of Camel Whey Protein and Camel Whey Protein Nanoparticles for Treating Intra-bony Periodontal Defects · NA · active not recruiting
- NCT07312045 — HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T · recruiting
- NCT07384221 — Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients · recruiting
- NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting
- NCT06848790 — Interdental Hygiene Methods in Young Adults · NA · recruiting
Other Arab American University (Palestine) trials
Trials by the same sponsor.
- NCT07404917 — Kinesio Taping for Lacertus Syndrome · NA · not yet recruiting
- NCT06427486 — Telecoaching Intervention for Children With Autism and Their Parents in Palestine · NA · not yet recruiting
- NCT06358976 — Anti-Spastic Splint With Focal Muscle Vibration for Stroke Hand Spasticity · NA · not yet recruiting
- NCT07152938 — Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoi · NA · completed
- NCT05827211 — The Usefulness of Antibiotics in Smokers Receiving Dental Implants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05756946 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arab American University (Palestine)
- Last refreshed: 20 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756946.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing